Skip to main content

Advertisement

SpringerLink
Log in

Influence of CCR5-Δ32 genotype in Spanish population with multiple sclerosis

  • Original Article
  • Published:
Neurogenetics Aims and scope Submit manuscript

Abstract

A number of association studies have explored the relationship between the CCR5-Δ32 allele and the risk of developing multiple sclerosis (MS), with varying results. In light of the results of several studies that have analyzed the role of the allele in MS, it has been proposed that the allele is involved in the etiopathogeny of the disease. Our study revealed a statistically significant difference between the study group and the control group for the carriers of at least one deleted allele (P = 0.027). The allele was more frequent in the control group, which suggests a possible protective effect of this deletion against MS. When ethnic origin was taken into account in the same analysis, we saw that the bulk of the difference was attributable to the Basque group, although the trend was also visible in the control group. Consideration of ethnic origin is therefore essential for the analysis of our sample. CCR5-Δ32 allele distribution was higher in the Basque control population than in the Basque MS population, which suggests that it confers a protective effect against MS. Relevant values were a P value of 0.008 and an odds ratio of 0.168 (95% confidence interval, 0.038 to 0.737).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fernandez O, Luque G, San RC, Bravo M, Dean G (1994) The prevalence of multiple sclerosis in the Sanitary District of Velez-Malaga, southern Spain. Neurology 44(3 Pt 1):425–429

    PubMed  CAS  Google Scholar 

  2. Rodríguez-Antiguedad AR (1999) Esclerosis múltiple, análisis clínico retrospectivo y prospectivo de una serie hospitalaria de base poblacional. Dissertation, UPV/EHU

  3. Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, De La Concha EG et al (2003) A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. J Neuroimmunol 143(1–2):124–128

    Article  PubMed  CAS  Google Scholar 

  4. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O et al (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74(1):160–167

    Article  PubMed  CAS  Google Scholar 

  5. Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J et al (2002) The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. J Neuroimmunol 130(1–2):194–201

    Article  PubMed  CAS  Google Scholar 

  6. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J et al (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38(10):1166–1172

    Article  PubMed  CAS  Google Scholar 

  7. Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ et al (2005) CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J Neuroimmunol 169(1–2):137–143

    Article  PubMed  CAS  Google Scholar 

  8. Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108–115

    Article  PubMed  CAS  Google Scholar 

  9. Simpson J, Newcombe J, Cuzner ML, Woodroofe M (2000) Expression of the intereferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26:133–142

    Article  PubMed  CAS  Google Scholar 

  10. Weiss J, Downie S, Lyman W, Berman J (1998) Astrocyte-derived monocyte-chemottractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J Immunol 161:6896–6903

    PubMed  CAS  Google Scholar 

  11. Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A et al (2002) A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 125(Pt 6):1337–1347

    Article  PubMed  Google Scholar 

  12. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G (1996) A full genome search in multiple sclerosis. Nat Genet 13:472–476

    Article  PubMed  CAS  Google Scholar 

  13. Benkirane M, jin D, Chun R, Koup R, Jeang K (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5Ä32. J Biol Chem 272:30603–30606

    Article  PubMed  CAS  Google Scholar 

  14. Zapico I, Coto E, Rodriguez A, Alvarez V, Torre J, Alvarez C (2000) CCR5 (chemochine receptor-5) DNA-polymorphisms influences the severity of rheumatoid arthritis. Genes Immun 1:288–289

    Article  PubMed  CAS  Google Scholar 

  15. Reynes J, Portales P, Segondy M (2001) CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. Aids 15:1627–1634

    Article  PubMed  CAS  Google Scholar 

  16. Jalonen T, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I (2002) Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. J Neurol 249:576–583

    Article  PubMed  CAS  Google Scholar 

  17. Pulkkinen K, Luomala M, Kuusisto H, Lehtimaki T, Saarela J, Jalonen T et al (2004) Increase in CCR5 Ä32/Ä32 genotype in multiple sclerosis. Acta Neurol Scand 109:342–347

    Article  PubMed  CAS  Google Scholar 

  18. Silversides JA, Heggarty SV, McDonnell GV, Hawkins SA, Graham CA (2004) Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler 10(2):149–152

    Article  PubMed  CAS  Google Scholar 

  19. Gade-Andavolu R, Comings DE, MacMurray J, Rostamkhani M, Cheng L, Tourtellotte W et al (2004) Association of CCR5 Ä32 deletion with early death in multiple sclerosis. Genet Med 3:126–131

    Article  CAS  Google Scholar 

  20. Favorova OO, Favorov AV, Boiko AN, Andreewski TV, Sudomoina MA, Alekseenkov AD et al (2006) Three allele combinations associated with multiple sclerosis. BMC Med Genet 7(1):63

    Article  PubMed  CAS  Google Scholar 

  21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127

    Article  PubMed  CAS  Google Scholar 

  22. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 33:144–152

    Google Scholar 

  23. Otaegui D, Saenz A, Martinez-Zabaleta M, Villoslada P, Fernandez-Manchola I, Alvarez dA et al (2004) Mitochondrial haplogroups in Basque multiple sclerosis patients. Mult Scler 10(5):532–535

    Article  PubMed  CAS  Google Scholar 

  24. Ristic S, Lovrecic L, Starcevic-Cizmarevic N, Brajenovic-Milic B, Jazbec SS, Barac-Latas V et al (2006) No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients. Mult Scler 12(3):360–362

    Article  PubMed  Google Scholar 

  25. Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R et al (2000) CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple sclerosis genetics group. Immunogenetics 51(4–5):281–288

    Article  PubMed  CAS  Google Scholar 

  26. Mahad DJ, Trebst C, Kivisakk P, Staugaitis SM, Tucky B, Wei T et al (2004) Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. J Neuropathol Exp Neurol 63(3):262–273

    PubMed  CAS  Google Scholar 

  27. Kantor R, Bakhanashvili M, Achiron A (2003) A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 61(2):238–240

    PubMed  CAS  Google Scholar 

  28. Elovaara I, Kuusisto H, Paalavuo R, Sarkijarvi S, Lehtimaki T, Huhtala H et al (2006) Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation. Acta Neurol Scand 113(3):163–166

    Article  PubMed  CAS  Google Scholar 

  29. Julia E, Montalban X, Al-Zayat H, Issazadeh-Navikas S, Goertsches R, Martin R et al (2006) Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis. J Neuroimmunol 180:147–158

    Article  PubMed  CAS  Google Scholar 

  30. Otaegui D, Saenz A, Ruiz-Martinez J, Olaskoaga J, Lopez de Munain A (2006) UCP2 and mitochondrial haplogroups as an MS risk-factor. Mult Scler (in press)

  31. Peterlin B, Ristic S, Sepcic J, Koncan Vracko B, Rako A, Lovrecic L et al (2006) Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia. J Neurol Sci 247:169–172

    Article  PubMed  Google Scholar 

  32. Kurtzke JF (2000) Epidemiology of multiple sclerosis. Does this really point toward an etiology? Neurol Sci 21:383–403

    Article  PubMed  CAS  Google Scholar 

  33. Paisan-Ruiz C, Jain S, Evans E, Gilks W, Simon J, Van der Brug M et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44(4):595–600

    Article  PubMed  CAS  Google Scholar 

  34. Cobo AM, Saenz A, Poza JJ, Urtasun M, Indakoetxea B, Urtizberea JA et al (2004) A common haplotype associated with the Basque 2362AG → TCATCT mutation in the muscular calpain-3 gene. Hum Biol 76(5):731–741

    Article  PubMed  Google Scholar 

  35. Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM et al (1998) Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 121(Pt 9):1735–1747

    Article  PubMed  Google Scholar 

  36. Saenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D et al (2005) LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 128(Pt 4):732–742

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the patients who took part in the study, Sabin Urcelay for her help in obtaining control samples, and Dr. Villoslada, Dr. Alvarez de Arcaya, Dr. Bergaretxe, Dr. Urtasun, Dr. Martí-Massó, and Dr. Carrera y Mantxola for their help in obtaining samples from patients. We also thank Asunción Iribarren and Olaia Zuriarrain for their invaluable technical assistance, and Marisa Martínez and Nati Coll for their help with obtaining samples. David Otaegui is a predoctoral student with a grant from the Basque Government. This study was partially funded by the Ilundain Fundazioa foundation and the Fundación Salud 2000.

Author information

Authors and Affiliations

  1. Unidad Experimental, Hospital Donostia, San Sebastian, Spain

    D. Otaegui

  2. Servicio de Neurología, Hospital Donostia, San Sebastian, Spain

    J. Ruíz-Martínez, J. Olaskoaga & A. López de Munain

  3. Unidad de Epidemiología, Hospital Donostia, San Sebastian, Spain

    J. I. Emparanza

  4. Fundación Ilundain, San Sebastián, Spain

    D. Otaegui & A. López de Munain

Authors
  1. D. Otaegui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Ruíz-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Olaskoaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. I. Emparanza
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. López de Munain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Otaegui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Otaegui, D., Ruíz-Martínez, J., Olaskoaga, J. et al. Influence of CCR5-Δ32 genotype in Spanish population with multiple sclerosis. Neurogenetics 8, 201–205 (2007). https://doi.org/10.1007/s10048-007-0085-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-007-0085-1

Keywords

Search

Navigation